Goal #1: Advance clinical and translational science

A person’s use of health care services before a COVID-19 infection may be the strongest predictor of whether they will get long COVID after an infection. These findings are according to a study of electronic health records (EHRs) from 55,257 people in the <a href="https://ncats.nih.gov/research/research-activities/n3c/overview" target="_blank" rel="noopener noreferrer">National Clinical Cohort Collaborative (N3C)</a> database. The study results could help clinicians better focus preventive efforts on people at greater risk for getting long COVID.&nbsp;Researchers at the University of California, Berkeley, and their colleagues conducted their study as part of the NIH <a href="https://www.challenge.gov/?challenge=l3c" target="_blank" rel="noopener noreferrer">Long COVID Computational Challenge</a>. Long COVID includes a range of long-term symptoms that people have after acute COVID-19. The N3C database has EHRs from more than 8 million people who have had COVID-19…&nbsp;Read the full article <a href="https://ncats.nih.gov/news-events/news/n3c-study-shows-health-factors-covid-19-infection-may-predict-long-covid-risk" target="_blank" rel="noopener noreferrer">here</a>.

National Institutes of Health (NIH)

medium_NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

small_NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

thumbnail_NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

National Center for Advancing Translational Sciences

N3C Study Shows Health Factors Before COVID-19 Infection May Predict Long COVID Risk

- Any -

Goal #5: Provide a national resource for public health needs

In a significant milestone for University of California (UC) San Diego, the Altman Clinical and Translational Research Institute (ACTRI), and the Division of Biomedical Informatics, the contract for the California Integrated Vital Records System (Cal-IVRS), one of the most advanced vital records systems in the world, was recently renewed for a period of three more years through June of 2027. This contract, a $25 million interagency agreement between UC San Diego and the California Department of Public Health (CDPH), highlights UC’s more than 42 years of unwavering commitment to providing the best-in-class electronic vital records and statistics for California. This collaborative effort will continue to be led by the Division of Bioinformatics faculty, Amy Sitapati, M.D. and Michael Hogarth, M.D., who also serves as the ACTRI Director of Bioinformatics and UC San Diego’s inaugural Clinical Research Information Officer.&nbsp;Data generated from the registration of vital events (births, deaths, fetal deaths) is critical for driving public health policies in today’s world and has both legal and epidemiological implications in the modern society. The federal government funds the acquisition of vital statistics data from states and territories through a variety of cooperative programs across both the National Center for Health Statistics, a part of the CDC, and Social Security Administration. While most states began manually entering vital records registration data into a centralized computer at the state offices by the early 1980s, Ron Williams of UC Santa Barbara was the first one to computerize the capture of vital events data at the source when he developed and implemented the Automated Vital Statistics System (AVSS) in 1982. AVSS, over nearly three decades, was very successful in registering over 27 million birth events in California. In 2004, Dr. Hogarth’s team developed CA-EDRS, a pioneering web-based death registration system, which began service for the CDPH on January 1, 2005, and has since processed over 4.2 million death certificates. In 2018, the system was upgraded to include birth registrations and transitioned from UC Davis to UC San Diego, with Dr. Sitapati joining the leadership. Now known as the Cal-IVRS, it is one of the world's most advanced electronic vital records systems…&nbsp;Read the full article <a href="https://actri.ucsd.edu/news/in-the-news/cal-ivrs-renewal.html" target="_blank" rel="noopener noreferrer">here</a>.

UC San Diego Clinical and Translational Research Institute

large_2023-01-27-202459.827580LogoCDPH-jpg-v3-Color.jpg

medium_2023-01-27-202459.827580LogoCDPH-jpg-v3-Color.jpg

small_2023-01-27-202459.827580LogoCDPH-jpg-v3-Color.jpg

thumbnail_2023-01-27-202459.827580LogoCDPH-jpg-v3-Color.jpg

2023-01-27-202459.827580LogoCDPH-jpg-v3-Color.jpg

University of California, San Diego

Cal-IVRS Renewal: Spearheading the Future of Public Health in California and Beyond

X-logo-teal_80x66.png

ri_linkedin_fill_408497d4b5_96748f4451.png

Goal #6: Enhance training programs 

Mentorship is critical for career and skill development in clinical and translational research, but locating practical resources on how to initiate, build, maintain, and assess these relationships is often challenging. To fill this gap, Harvard Catalyst has developed a new guide with popular resources adapted from their course and program content to help both mentees and mentors at all career stages maximize their relationships and grow their networks. Read the full article <a href="https://catalyst.harvard.edu/mentorship-in-clinical-and-translational-research/" target="_blank" rel="noopener noreferrer">here</a>.

Harvard Clinical and Translational Science Center

Harvard Catalyst. Mentorship in Clinical and Translational Research. A guide to empower mentees and mentors in maximizing their mentoring relationships and growing their networks.

large_harvard mentorship.PNG

medium_harvard mentorship.PNG

small_harvard mentorship.PNG

thumbnail_harvard mentorship.PNG

harvard mentorship.PNG

Harvard Medical School

Harvard Clinical and Translational Science Center's New Guide on Mentorship in Clinical and Translational Research

CTSA CCOS

Home

About

CTSA Groups and Meetings

Resources

News

Help

CTSA News

Date

Share this News Post

N3C Study Shows Health Factors Before COVID-19 Infection May Predict Long COVID Risk